A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3

Journal of Virology

Volumn 71, Issue 2, 1997, Pages 1608-1620

  Hirsch, Vanessa ^a   Adger Johnson, Diane ^a   Campbell, Barbara ^a   Goldstein, Simoy ^a   Brown, Charles ^a   Elkins, William R ^a   Montefiori, David C ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENE MAPPING; HELPER CELL; IMMUNE DEFICIENCY; MOLECULAR CLONING; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS NEUTRALIZATION; VIRUS RESISTANCE;

EID: 0031033036     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.2.1608-1620.1997     Document Type: Article

References (68)

1. Anderson, M., D. Hauer, D. P. Sharma, S. V. Joag, O. Narayan, M. C. Zink, and J. E. Clements. 1993. Analysis of envelope changes acquired by SIV-mac239 during neuroadaptation in rhesus macaques. Virology 195:616-626.
2. Arthur, L. Q., J. W. Bess, R. C. Sowder, R. E. Benveniste, D. L. Mann, J.-C. Chermann, and L. E. Henderson. 1991. Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 258:1935-1938.
3. Ashkenazi, A., D. H. Smith, S. A. Marsters, L. Riddle, T. J. Gregory, D. D. Ho, and D. J. Capon. 1991. Resistance of primary HIV-1 isolates to soluble CD4 is independent of CD4-gp120 binding affinity. Proc. Natl. Acad. Sci. USA 88:7056-7060.
4. Asjo, B., J. Albert, A. Karlsson, L. Mordfeldt-Manson, G. Bibberfeld, K, Lidman, and E. M. Fenyo. 1986. Replicative properties of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet ii:660-662.
5. Banapour, B., M. L. Marthas, R. A. Ramos, B. L. Lohman, R. E. Unger, M. B. Gardner, N. C. Pederson, and P. A. Luciw. 1991. Identification of viral determinants of macrophage tropism for simian immunodeficiency virus, SIVmac. J. Virol. 65:5798-5805.
6. Baskin, G., L. N. Martin, M. Murphey-Corb, F.-S. Hu, D. Kuebler, and B. Davison. 1995. Distribution of SlV in lymph nodes of serially sacrificed rhesus monkeys. AIDS Res. Hum. Retroviruses 11:273-285.
7. Baskin, G. B., M. Murphey-Corb, E. A. Watson, and L. N. Martin. 1989. Necropsy findings in rhesus monkeys experimentally infected with cultured simian immunodeficiency virus (SIV/Delta). Vet. Pathol. 25:456-467.
8. Bou-Habib, D. C., G. Roderiquez, T. Oravecz, P. W. Berman, P. Lusso, and M. A. Norcross. 1994. Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization. J. Virol. 68:6006-6013.
9. Campbell, B., and V. M. Hirsch. 1994. Extensive envelope heterogeneity of simian immunodeficiency virus in tissues from infected macaques. J. Virol. 68:3129-3137.
10. Cheng-Mayer, C., D. Seto, M. Tateno, and J. A. Levy. 1988. Biologic features of HIV-1 that correlate with virulence in the host. Science 240:80-82.
11. Chesbro, B., K. Wehrly, J. Nishio, and S. Perryman. 1992. Macrophagetropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J. Virol. 66:6547-6554.
12. Choe, H., M. Farazan, Y. Sun, N. Sullivan, B. Rollins, P. D. Panath, L. Wu, C. R. Mackay, G. LaRosa, W. Newman, N. Gerard, C. Gerard, and J. Sodroski. 1996. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135-1148.
13. Choi, W. S., C. Collignon, C. Thiriart, D. P. W. Burns, E. J. Stott, K. A. Kent, and R. C. Desrosiers. 1994. Effects of neutral sequence variation on recognition of monoclonal antibodies that neutralize simian immunodeficiency virus infectivity. J. Virol. 68:5395-5402.
14. Cocchi, F., A. De Vico, A. Garzino-Demo, S. Arya, R. Gallo, and P. Lusso, 1995. Identification of RANTES, MlP-1α. and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 270:1811-1815.
15. Connor, R. I., H. Mohri, Y. Cao, and D. D. Ho. 1993. Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type-1-infected individuals. J. Virol. 67:1772-1777.
16. Daar, E. S., X. L. Li, T. Moudgil, and D. D. Ho. 1990. High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates. Proc. Natl. Acad. Sci. USA 87:6574-6578.
17. de Jong, J. J., J. Goudsmit, W. Keulen, B. Klaver, W. Krone, M. Tersmette, and T. de Ronde. 1992. Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity. J. Virol. 66:757-765.
18. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. DiMarzio, S. Marmon, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, D. R. Littman, and N. R. Landau. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661-666.
19. Desrosiers, R. C., A. Hansen-Moosa, K. Mori, D. P. Bouvier, N. W. King, M. D. Daniel, and D. J. Ringler. 1991. Macrophage tropic variants of SIV are associated with specific AIDS-related lesions but are not essential for the development of AIDS. Am. J. Pathol. 139:29-35.
20. Doranz, B. J., J. Rucker, Y. Yi, R. J. Smyth, M. Samson, S. C. Peiper, M. Parmentier, R. G. Collman, and R. Doms. 1996. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR2b as fusion cofactors. Cell 85:1149-1158.
21. Dragic, T., V. Litwin, G. P. Allaway, S. R. Martin, Y. Huang, K. A. Nagashima, C. Cayanan, P. J. Maddon, R. A. Koup, J. P. Moore, and W. A. Paxton. 1996. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-673.
22. D'Souza, M. P., K. A. Kent, C. Thiriart, C. Collignon, and G. Milman. 1993. International collaboration comparing neutralization and binding assays for monoclonal antibodies to simian immunodeficiency virus. AIDS Res. Hum. Retroviruses 9:415-422.
23. Epstein, L., C. Kuiken, B. Blumberg, S. Hartman, L. Sharer, M. Clement, and J. Goudsmit. 1991. HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue-specific evolution within host-determined quasi-species. Virology 180:583-590.
24. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry co-factor: functional cDNA cloning of a seven transmembrane, G proteincoupled receptor. Science 272:872-877.
25. Fenyo, E. M., and E. Norrby. 1991. Biological variation of human immunodeficiency viruses and evolution of the late pathogenic infection in vivo, p. 149-164. In, W. Koff, F. Wong-Staal, and R. Kennedy (ed.), AIDS research reviews, 1st ed. Marcel Dekker, Inc., New York, N.Y.
26. Fouchier, R. A. M., M. Groenink, N. A. Koostra, M. Tersmette, H. G. Huisman, F. Miedema, and H. Schuitemaker. 1992. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J. Virol. 66:3183-3187.
27. Golding, H., M. P. D'Souza, J. Bradac, B. Mathieson, and P. Fast. 1994. Neutralization of HIV-1. AIDS Res. Hum. Retroviruses 10:623-643.
28. Graham, B. S. 1994. Serologic responses to candidate AIDS vaccines. AIDS Res. Hum. Retroviruses 10:S145-S148.
29. Grimaila, R. J., B. A. Fuller, P. D. Rennert, M. B. Nelson, M.-L. Hammarskjöld, B. Potts, M. Murray, S. D. Putney, and G. Gray. 1992. Mutations in the principal neutralization determinant of human immunodeficiency virus type I affect syncytium formation, virus infectivity, growth kinetics, and neutralization. J. Virol. 66:1875-1883.
30. Hanson, C. V. 1994. Measuring vaccine-induced HIV neutralization: report of a workshop. AIDS Res. Hum. Retroviruses 10:645-648.
31. Hirsch, V., R. Olmsted, M. Murphey-Corb, R. Purcell, and P. Johnson. 1989. An African primate lentivirus (SIVsm) closely related to HIV-2. Nature 339:389-392.
32. Hirsch, V. M., P. Edmondson, M. Murphey-Corb, B. Arbeille, P. R. Johnson, and J. I. Mullins. 1989. SIV adaptation to human cells. Nature 341:573-574.
33. Hirsch, V. M., P. M. Zack, A. P. Vogel, and P. R. Johnson. 1991. Simian immunodeficiency virus infection of macaques: end-stage disease is characterized by widespread distribution of proviral DNA in tissues. J. Infect. Dis. 163:976-988.
34. Hirsch, V. M., and P. R. Johnson. 1994. Pathogenic diversity of simian immunodeficiency viruses. Virus Res. 32:183-203.
35. Hirsch, V. M., G. Myers, and P. R. Johnson. 1993. Genetic diversity and phytogeny of primate lentiviruses, p. 221-240. In W. J. W. Morrow and N. L. Haigwood (ed.), HIV molecular organization, pathogenicity and treatment. Elsevier Science Publishers B.V., Amsterdam, The Netherlands.
36. Hirsch, V. M., S. Goldstein, N. A. Hynes, W. R. Elkins, W. T. London, P. M. Zack, D. Montefiori, and P. R. Johnson. 1994. Prolonged clinical latency and survival of macaques given a whole inactivated simian immunodeficiency virus vaccine. J. Infect. Dis. 170:51-59.
37. Hirsch, V. M., J. E. Martin, G. Dapolito, W. R. Elkins, W. T. London, S. Goldstein, and P. R. Johnson. 1994. Spontaneous substitutions in the vicinity of the V3 analog affect cell tropism and pathogenicity of simian immunodeficiency virus. J. Virol. 68:2649-2661.
38. Hirsch, V. M., G. Dapolito, P. R. Johnson, W. R. Elkins, W. T. London, S. Goldstein, R. Montali, and C. Brown. 1995. Induction of AIDS by simian immunodeficiency virus from an African green monkey: species-specific variation in pathogenicity correlates with extent of in vivo replication. J. Virol. 69:955-967.
39. Kestler, H., T. Kodama, D. Ringler, M. Marthas, N. Pederson, A. Lackner, D. Reiger, P. Seghal, M. Daniel, N. King, and R. C. Desrosiers. 1990. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science 248:1109-1112.
40. Kodama, T., D. Wooley, Y. M. Naidu, H. W. Kestler, M. D. Daniel, Y. Li, and R. C. Desrosiers. 1989. Significance of premature stop codons in env of simian immunodeficiency virus. J. Virol. 63:4709-4714.
41. Koyanagi, Y., S. Miles, R. T. Mitsuyasu, J. E. Merrill, H. V. Vinters, and I. S. T. Chen. 1987. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 236:819-822.
42. Letvin, N., and N. King. 1990. Immunologic and pathologic manifestations of the infection of rhesus monkeys with simian immunodeficiency virus of macaques. J. Acquired Immune Defic. Syndr. 3:1023-1040.
43. Matthews, T. J. 1994. Dilemma of neutralization resistance of HIV-1 field isolates and vaccine development. AIDS Res. Hum. Retroviruses 10:631-632.
44. McClure, H. M., D. C. Anderson, P. N. Fultz, A. A. Ansari, E. Lockwood, and A. Brodie. 1989. Spectrum of disease in macaque monkeys chronically infected with SIV/SMM. Vet. Immunol. Immunopathol. 21:13-24.
45. Montefiori, D. C, W. E. Robinson, Jr., S. S. Schuffman, and W. M. Mitchell. 1988. Evaluation of antiviral drugs and neutralizing antibodies against human immunodeficiency virus by a rapid and sensitive microtiter infection assay. J. Clin. Microbiol. 26:231-235.
46. Montefiori, D. C., G. Panteleo, L. M. Fink, J. T. Zhou, M. Bilska, G. D. Miralles, and A. S. Fauci. 1996. Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors. J. Infect. Dis. 173:60-67.
47. Moore, J. P., Y. Cao, L. Qing, Q. J. Sattentau, J. Pyati, R. Koduri, J. Robinson, C. F. Barbas III, D. R. Burton, and D. D. Ho. 1995. Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120. and their neutralization is not predicted by studies with monomeric gp120. J. Virol. 69:101-109.
48. Moore, J. P., and D. D. Ho. 1995. HIV-1 neutralization: the consequences of viral adaptation to growth on transformed T cells. AIDS 9:S117-S136.
49. Mori, K., D. J. Ringler, T. Kodama, and R. C. Desrosiers. 1992. Complex determinants of macrophage tropism in env of simian immunodeficiency virus. J. Virol. 66:2067-2075.
50. Orentas, R. J., and J. E. Hidreth. 1993. Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV. AIDS Res. Hum. Retroviruses 9:1157-1165.
51. Overbaugh, J., L. M. Rudensey, M. D. Papenhausen, R. Benveniste, and W. R. Morton. 1991. Variation in simian immunodeficiency virus env is confined to V1 and V4 during progression to simian AIDS. J. Virol. 65: 7025-7031.
52. Pang, S., H. V. Vinters, T. Akashi, W. A. O'Brien, and I. S. Y. Chen. 1991. HIV-1 Env sequence variation in brain tissue of patients with AIDS-related neurologic disease. J. Acquired Immune Defic. Syndr. 4:1082-1092.
53. Reimann, K., K. Tenner-Racz, P. Racz, D. Montefiori, Y. Yasutomi, W. Lin, B. J. Ransil, and N. L. Letvin. 1994. Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. J. Virol. 68:2368-2370.
54. Richman, D. D., and S. A. Bozzette. 1994. The impact of the syncytiuminducing phenotype of human immunodeficiency virus on disease progression. J. Infect. Dis. 169:968-974.
55. Sawyer, L. W., M. T. Wrin, L. Crawford-Mikza, B. Potts, Y. Wu, P. A. Weber, R. D. Alfonso, and C. V. Hansom. 1994. Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated. J. Virol. 68:1342-1349.
56. Schuitemaker, H., M. Koot, N. A. Koostra, M. Wouter Derksen, Y. E. Y. deGoede, R. P. van Steenwijk, J. M. A. Lange, J. K. M. Eeftink Schattenkerk, F. Miedema, and M. Tersmette. 1992. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J. Virol. 66:1354-1360.
57. Sharma, D. P., M. Anderson, M. C. Zink, R. J. Adams, A. D. Donnenberg, J. E. Clements, and O. Narayan. 1992. Pathogenesis of acute infection in rhesus macaques with a lymphocyte-tropic strain of simian immunodeficiency virus. J. Infect. Dis. 166:738-746.
58. Shioda, T., J. A. Levy, and C. Cheng-Mayer. 1991. Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature 349:167-169.
59. Simon, M., L. Chalifoux, and D. Ringler. 1992. Pathologic features of SIV-induced disease and the association of macrophage infection with disease evolution. AIDS Res. Hum. Retroviruses 8:327-337.
60. Simon, M. A., S. J. Brodie, V. G. Sasseville, L. V. Chalifoux, R. C. Desrosiers, and D. J. Ringler. 1994. Immunopathogenesis of SIVmac. Virus Res. 32: 227-251.
61. Spira, A. I., P. A. Marx, B. K. Patterson, J. Mahoney, R. A. Koup, S. M. Wolinsky, and D. D. Ho. 1996. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J. Exp. Med. 183:215-225.
62. Staprans, S. I., B. L. Hamilton, S. E. Follansbee, T. Elbeik, P. Barbosa, R. M. Grant, and M. B. Feinberg. 1995. Activation of virus replication after vaccination of HIV-1-infected individuals. J. Exp. Med. 182:1727-1737.
63. 63: Sullivan, N., Y. Sun, J. Li, W. Hofmann, and J. Sodroski. 1995. Replicative nction and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. J. Virol. 69:4413-4422.
64. Van't Wout, A. B., N. A. Koostra, G. A. Mulder-Kampinga, N. Albrecht-van Lent, H. J. Scherpbier, J. Veenstra, K. Boer, R. A. Countinho, F. Miedema, and H. Schuitemaker. 1994. Macrophage tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral and vertical transmission. J. Clin. Invest. 94:2060-2067.
65. Ward, J. M., T. J. O'Leary, G. B. Baskin, R. Benveniste, C. A. Harris, P. L. Nara, and R. H. Rhodes. 1987. Immunohistochemical localization of human immunodeficiency viral antigens in fixed tissue sections. Am. J. Pathol. 127: 199-205.
66. . Weiss, P., M. Wallace, E. Oldfield, J. O'Brien, and E. Janoff. 1995. Response of recent human immunodeficiency virus seroconverters to pneumococcal polysaccharide vaccine and Haemophilus influenzae type B conjugate vaccine. J. Infect. Dis. 171:1217-1222.
67. Wyand, M. S., D. J. Ringler, Y. M. Naidu, M. Mattmuller, L. V. Chalifoux, P. K. Seghal, M. D. Daniel, R. C. Desrosiers, and N. W. King. 1989. Cellular localization of simian immunodeficiency virus in lymphoid tissues. II. In situ hybridization. Am. J. Pathol. 134:385-393.
68. Zhang, J., L. N. Martin, E. A. Watson, R. C. Montelaro, M. West, L. Epstein, and M. Murphey-Corb. 1988. Simian immunodeficiency virus/Delta-induced immunodeficiency disease in rhesus monkeys: relation of antibody response and antigenemia. J. Infect. Dis. 158:1277-1286.